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Abstract
Background: Sensitivity of breast tumors to anticancer drugs depends upon dynamic interactions
between epithelial tumor cells and their microenvironment including stromal cells and extracellular
matrix. To study drug-sensitivity within different compartments of an individual tumor ex vivo,
culture models directly established from fresh tumor tissues are absolutely essential.
Methods: We prepared 0.2 mm thick tissue slices from freshly excised tumor samples and
cultivated them individually in the presence or absence of taxol for 4 days. To visualize viability, cell
death, and expression of surface molecules in different compartments of non-fixed primary breast
cancer tissues we established a method based on confocal imaging using mitochondria- and DNA-
selective dyes and fluorescent-conjugated antibodies. Proliferation and apoptosis was assessed by
immunohistochemistry in sections from paraffin-embedded slices. Overall viability was also
analyzed in homogenized tissue slices by a combined ATP/DNA quantification assay.
Results: We obtained a mean of 49 tissue slices from 22 breast cancer specimens allowing a wide
range of experiments in each individual tumor. In our culture system, cells remained viable and
proliferated for at least 4 days within their tissue environment. Viability of tissue slices decreased
significantly in the presence of taxol in a dose-dependent manner. A three-color fluorescence
viability assay enabled a rapid and authentic estimation of cell viability in the different tumor
compartments within non-fixed tissue slices.
Conclusion: We describe a tissue culture method combined with a novel read out system for
both tissue cultivation and rapid assessment of drug efficacy together with the simultaneous
identification of different cell types within non-fixed breast cancer tissues. This method has
potential significance for studying tumor responses to anticancer drugs in the complex
environment of a primary cancer tissue.
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Background
It is becoming increasingly evident that the development
of cancer and response to anticancer drug therapy not
only depend on discrete genetic alterations in the malig-
nant clone but also on specific interactions between
tumor cells and surrounding tissue components. The
mammary gland is composed of different cell types and
extracellular matrix proteins [1]. In the normal gland,
luminal epithelial cells in the ducts are encased by myoep-
ithelial cells which are in contact with a basement mem-
brane. This intact basement membrane separates
epithelial cells from a surrounding highly compartmen-
talized stroma which accounts for more than 80% of the
normal breast volume [2]. Conversely, in invasive carci-
noma, fully differentiated myoepithelial cells and intact
basement membranes are often lost and tumor cells are in
direct contact with a highly activated collagenous tumor-
stroma [3,4]. Our understanding of interactions between
epithelium and stroma within the cancerous mammary
gland and their role for drug responsiveness is still rudi-
mentary. Obviously, this is because most established in
vitro models fail to reflect the complex tissue architecture
of an individual tumor.
The majority of preclinical breast cancer research is based
on established cell lines [5]. However, these cell lines fre-
quently have undergone multiple changes influencing
their biological behavior and therefore no longer reflect
the primary tumor of origin. Freshly isolated primary epi-
thelial cells, in contrast, may be more closely related to the
malignant epithelial cells of the tumor [5]. Also, it is diffi-
cult to adapt the cells of many tumors to in vitro condi-
tions when establishing a primary epithelial culture. In
addition, it is most likely that separated tumor cells will
behave differently in vitro, as both cell-cell and cell-matrix
interactions are highly different compared to the in vivo
situation. Therefore, to investigate tumor cell behavior ex
vivo it is necessary to maintain or reconstitute an environ-
ment closely resembling the tumor tissue. To simulate
such conditions either three-dimensional tissue cultures
using several biomatrices or co-culture experiments with
tumor fibroblasts have been performed [6,7]. These stud-
ies have provided important information concerning both
the impact of communication between tumor cells and
fibroblasts and the interaction between extracellular
matrix, integrins, and various intracellular signal cascades
in epithelial cells [7-10]. However, these systems can not
mimic the complex tissue architecture and the high degree
of variability seen in individual tumors. One possibility to
maintain the tissue architecture ex vivo is the direct culti-
vation of fresh and intact tumor material. First experi-
ments in this direction were performed in 1967 by
Matoska and Stricker using tumor cubes of approximately
1 mm3 [11]. A problem that arose in this approach was
restricted diffusion of oxygen and nutrients leading to cell
death in the center of the tissue cubes. This was overcome
by the introduction of a tissue microtome enabling the
preparation of thin tissue slices [12-15]. We have
improved this tissue culture system to study the activity of
anticancer drugs such as taxol in different tissue compart-
ments. The use of a confocal laser scan microscopy based
technique enabled us to identify cell type and test cell via-
bility in tissue slices maintained for at least 4 days in cul-
ture.
Methods
Tissue slice preparation and culture
Fresh sterile tissue of primary breast tumors larger than 3
cm were obtained as surgical waste from patients newly
diagnosed for breast cancer of invasive ductal type (n =
24) and mucinous type (n = 1) at the Robert Bosch Hos-
pital immediately after surgical resection and maintained
in organ transportation medium (Eurocollins, Fresenius
medical care, Bad Homburg, Germany) on ice until use.
This investigation was approved by the local ethics com-
mittee and informed consent was obtained from the
patients. Patients treated with neoadjuvant chemotherapy
were excluded. Tissue slice preparation is illustrated in fig-
ure 1. Tissue cores (5 mm in diameter) were prepared
under a sterile hood using a hand held coring tool. From
the cylinders, tissue slices with a thickness of 200µm were
Procedure of slice preparation and tissue cultivation Figure 1
Procedure of slice preparation and tissue cultivation.
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prepared in cold PBS using a precision cutting tissue slicer
(Krumdieck, Alabama Research and Development Corp.,
Munsford, USA). To avoid contamination, all parts of the
tissue slicer which have contact to the tissue or buffer were
cleaned with 70% 2-propanol and steam sterilized before
use. Slices were then individually submerged in 1 ml
Mammary Epithelial Growth Medium supplemented with
bovine pituary extract, 10 ng/ml rhEGF, 5µg/ml bovine
Insulin, 500 ng/ml hydrocortisone, 100µg/ml gen-
tamicin, and 0.05µg/ml amphotericin B (PromoCell, Hei-
delberg, Germany). Incubation was performed in 24-well
plates at 37°C in a constant atmosphere of 5% CO2 on a
shaking platform with 150 rpm (Titramax 100, Heidolph,
Schwabach, Germany). Medium was changed every 24
hours. Treatment with taxol started after 24 hours and was
performed for an additional 72 hours. Taxol concentra-
tions were selected according to test drug concentrations
from a commercially available standard tumor chemosen-
sitivity assay (TCA-100; DCS Innovative Diagnostic sys-
tems, Hamburg, Germany). To investigate cell
proliferation, slices were incubated with 100µM BrdU and
1µM FdU for 4 h. Slices were then either transferred in a 2
mM EDTA solution (pH = 10.9) in ethanol (70% v/v) and
immediately frozen in liquid nitrogen, fixed in formalin,
cryo-conserved, or stained with fluorescent dyes for iden-
tification of cell type and viability.
Simultaneous identification of living and dead cells within 
tissue slices
To identify living and dead cells within the non-fixed tis-
sue slices, we established a three-color and two-color flu-
orescent viability assay. Living cells were detected using
tetramethylrhodamine methyl ester (TMRM; Molecular
Probes, Invitrogen, Karlsruhe, Germany). SYTO®63
(Molecular Probes, Invitrogen) is a low-affinity nucleic
acid stain that passively diffuses through the membranes
of living and dead cells. Picogreen (Molecular Probes, Inv-
itrogen) or propidium iodide (PI; Sigma-Aldrich, Deisen-
hofen, Germany) on the other hand, are DNA-selective
dyes that are membrane impermeant but that easily pass
through the compromised plasma membranes of dead
cells. For three-color fluorescent staining, cells or tissues
were incubated simultaneously with 0.5µM TMRM,
1.25µM SYTO®63, and a concentrated solution of
Picogreen in DMSO (Molecular Probes, Invitrogen) in a
1:1500 dilution in the culture medium at 37°C for 45 min
and analyzed immediately without further washing steps
using confocal microscopy. The two-color fluorescent
stain assay was performed using 1.25µM SYTO®63 and
either Picogreen (1:1500) or 0.2µg/ml PI in a PBS/1% BSA
solution for 30 min and examined immediately or follow-
ing additional antibody staining using confocal micros-
copy.
Identification of different tumor compartments within 
non-fixed tissue slices
Epithelial cells and endothelial cells were distinguishable
using fluorescent-labeled antibodies recognizing specific
surface markers. Slices were transferred in 1 ml PBS con-
taining 1% BSA and 1.25µM SYTO®63. After an incuba-
tion period of 30 min at 37°C, the volume was reduced to
100µl and conjugated antibody or Ulex europaeus Aggluti-
nin I (UEA-1) was added. Epithelial cells were identified
with a FITC-conjugated anti-HEA-125 antibody (1:20;
Biomeda, Foster City, CA). To visualize the vascular net-
work, fresh tissue slices were directly labeled using FITC-
conjugated UEA-1 (1:50; Alexis, Grunberg, Germany) or
phycoerythrin (PE)-conjugated CD34 antibody (1:20; BD
Biosciences Pharmingen, Heidelberg, Germany). Slices
were incubated with antibody or UEA-1 for 20 min at
4°C. The staining solution was removed and slices were
washed with cold PBS/BSA containing PI (0.2µg/ml) for
10 min. Slices were then transferred on microscope slides
and cells visualized using a confocal microscope with a
40× objective (Leica Lasertechnik, Wetzlar, Germany).
Confocal microscopy and triple-fluorescence analysis
Confocal laser scanning microscopy was performed using
a Leica LCS (Leica Lasertechnik) instrument based on a
Leica DM IRBE microscope interfaced with argon and
helium/neon lasers emitting at 488 nm, 543 nm and 633
nm. To separate the detection channels we used a spectro-
photometer. The different colors were detected sequen-
tially at 500–520 nm for Picogreen and FITC, 560–590
nm for TMRM, PE, and PI, and 650–700 nm for SYTO®63.
Quantification of triple-fluorescence viability assay
Confocal images were counted by two independent
observers. The numbers of TMRM+, SYTO®63+, and
Picogreen+ cells were evaluated by direct counting of at
least 50 cells from at least two different areas of the tissues
in 400× magnification images. Counts were expressed as
mean number (averaged between the observers) of
TMRM+, SYTO®63+, and Picogreen+ cells per image. The
ratio of vital cells (mean of TMRM+ and SYTO®63+ cells/
mean of total cells) and dead cells (mean of Picogreen+
cells/mean of total cells) was evaluated for each individ-
ual tumor.
Immunohistochemical staining
Tissue slices were fixed in 10% phosphate-buffered forma-
lin. For histopathological examination paraffin sections
(3µm) were stained with hematoxylin and eosin. Immu-
nohistochemical staining for CD34 (M7165; DakoCyto-
mation, Hamburg, Germany; 1:50), BrdU (anti-BrdU
clone BU-33, B2531, Sigma-Aldrich; 1:100), HEA
(M0804, DakoCytomation; 1:100) or Caspase 3 cleavage
product (#9661, Cell Signal Technology, Beverly, MA;
1:50) was performed using the Dako Envision Kit on aBMC Cancer 2006, 6:86 http://www.biomedcentral.com/1471-2407/6/86
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DakoCytomation Autostainer (both DakoCytomation)
according to the manufacturer's manual. Epitope retrieval
was achieved as follows: prior to staining for CD34, HEA,
and Caspase 3 cleavage product by treatment in a steam
heater for 15 min, and by incubation in 2 M HCl/0.1 M
borax at 37°C for 30 min followed by incubation with
pronase at 37°C for 30 min before staining for BrdU.
Counterstaining was performed with hematoxylin.
ATP quantification
Tissue slices were transferred into a 2 mM EDTA solution
(pH = 10.9) in ethanol (70% v/v) and immediately frozen
in liquid nitrogen. The slices were homogenized using lys-
ing matrix D and a FastPrep instrument (Qbiogene, Heidel-
berg, Germany). 50µl of slice homogenate were
transferred into 450µl phosphate buffer (0.1 M, pH =
7.5). The content of ATP was determined in this solution
using ATP Bioluminescence Assay Kit (DSC, Hamburg,
Germany). To correct for cell numbers within individual
slices, DNA content was measured in parallel using the
Picogreen DNA quantification system (Molecular
Probes).
Statistics
Calculation of means, standard deviation (SD), and
standard error of the mean (SEM) was done in GraphPad
Prism (V 3.0, GraphPad Prism Software Incorp., San
Diego, CA, USA). Different groups were compared by
Kruskal-Wallis test.
Results
Preparation of tissue slices
Circular punches of fresh tumor material were cut into
200µm slices in ice cold phosphate buffered saline (PBS)
using a Krumdieck microtome. These slices were individ-
ually submerged in 1 ml Mammary Epithelial Growth
Medium. Details of this procedure are illustrated in figure
1. Viable tissue slices were obtained from 22 of 25 breast
tumor samples. In one case the cells were completely dead
because of a prolonged transportation without transporta-
tion medium (Eurocollins), one was contaminated with
bacteria, and a mucinous carcinoma was too soft to cut.
Depending on the size of the individual tumor sample a
mean of 49 viable tissue slices (range: 24 – 130) were
obtained.
Identification of living and dead cells within non-fixed 
tissues
To identify living and dead cells within non-fixed tissue
slices, we established a two- and three-color fluorescent
viability assay composed of SYTO®63, and Picogreen or PI
for both assays and in addition TMRM for the three-color
assay. Living cells were detected with TMRM, a probe that
accumulates within polarized mitochondria, wherefrom
it is released completely upon depolarization. Picogreen
and PI are DNA-selective dyes that are membrane nonper-
meant but that easily pass through the compromised
plasma membranes of dead cells. Thus, these dyes selec-
tively detect dead cells. SYTO®63 on the other hand is a
lower-affinity nucleic acid stain that passively diffuses
through the membranes of living and dead cells. Cells or
tissues can be incubated simultaneously with these dyes
within the appropriate medium at 37°C for 45 min and
analyzed immediately using confocal microscopy. We
evaluated these methods using a Bcr-Abl positive hemat-
opoietic cell line treated with Imatinib (STI571) for a
short time period. Imatinib selectively kills Bcr-Abl posi-
tive cells [16]. As shown in figure 2a TMRM accumulates
in mitochondria of living cells and cannot be detected in
dead cells. Dead cells are characterized by a bright green
fluorescence due to Picogreen/DNA binding in the three-
color fluorescent assay and a red fluorescence due to PI/
DNA binding in the two-color fluorescent assay (Fig. 2a
and 2b). All cells are stained by SYTO®63 (Fig. 2a and 2b).
The comparison of the three-color fluorescent assay with
a widely accepted method for quantification of cell death
(Annexin V-FITC staining) by means of FACS analyses
revealed similar results (Fig. 2c). In addition, visually
counted evaluation of the three- and two-color based
assay using a confocal microscope gave equal results (Fig.
2d). Therefore, these assays allow a precise, simple, and
rapid estimation of viable and dead cells within non-fixed
tissue slices by confocal microscopy.
In tissue samples from breast tumor specimens SYTO®63
and TMRM labeled cells reflecting living cells were highly
concentrated throughout the slice. Figure 3a shows a rep-
resentative example of a tumor area stained with
Picogreen, SYTO®63 and TMRM. In analogy to the results
obtained with single cells (Fig. 2a), Picogreen and TMRM
staining was found to be mutually exclusive in tissue slices
(Fig. 3a). Histological examination of paraffin embedded
tissue slices cultivated for 4 days revealed no obvious dif-
ferences in the morphology when compared to the paraf-
fin embedded 'original' tumor tissue from routine
diagnosis (Fig. 3b). TMRM staining depends on the
proper functioning of the mitochondria. The mitochon-
drial metabolism may be influenced by growth factors
[17] and by low temperature. Following surgery the tis-
sues are kept in ice cold transportation medium (Eurocol-
lins) lacking growth factors until cultivation. The time
frame between surgery, preparation by the pathologist,
slicing, and cultivation was at least 3 hours. We therefore
avoided starting our experiments immediately after slice
preparation. Within 24 hours of cultivation, TMRM labe-
ling identified a high percentage of vital cells without sig-
nificant changes during the following 72 hours
(representative images in Fig. 3c). This was confirmed by
quantification of Picogreen+ cells in relation to total cells
in 6 tumor samples. The median ratios of dead cells atBMC Cancer 2006, 6:86 http://www.biomedcentral.com/1471-2407/6/86
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Principle of three and two-color fluorescence viability assay Figure 2
Principle of three and two-color fluorescence viability assay: Bcr-Abl positive BaF3 cells were cultivated in the pres-
ence of 1µM Imatinibfor 8 hours. (a) Following Imatinib treatment cells were incubated with TMRM (given color: red), 
SYTO®63 (given color: blue), and Picogreen (given color: green) and visualized using a confocal microscope with a 63X objec-
tive. (b) Following Imatinib treatment cells were incubated in a PBS-BSA solution containing PI (given color: red) and SYTO®63 
(given color: blue) and visualized by confocal microscopy. (c) Comparison of cell death indices determined by Annexin V-FITC 
staining or TMRM/Picogreen staining in Imatinib treated cells by means of FACS analysis. (d) Comparison of cell death indices 
determined by PI/SYTO63 staining or TMRM/Picogreen staining. Cells were visualized by confocal microscopy with a 40× 
objective. 10 different areas with each at least 20 cells were counted. Values are means of the ratio PI+ cells or Picogreen+ cells 
to total cells ± SD from 10 different areas.
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Viability of cultivated tissue slices Figure 3
Viability of cultivated tissue slices: Tumor slices obtained from a breast carcinoma were individually cultivated in 1 ml 
medium for 24 hours. Slices were then analyzed for cell viability or cultivated for additional 72 hours or 144 hours as indicated. 
(a) Representative example of a tissue slice stained with Picogreen, SYTO®63, and TMRM. (b) Hematoxylin and eosin (HE) 
staining of a section from a paraffin embedded tissue slice after a culture period of 96 hours in comparison to that observed in 
a section obtained from the same tumor directly after surgery ('original' tumor sample). (c) Cell viability after an ex vivo cultiva-
tion period of 24 and 96 hours determined by TMRM, SYTO®63, and Picogreen labeling. (d) Quantification of cell death 
(number of visually counted Picogreen+ cells in relation to the number of total cells in 3 different areas) in non fixed tumor 
slices from 6 patients. Values reflect means ± SEM (n = 6). (e) Ratio of luminescence based quantification of ATP to DNA con-
tent of homogenates from slices cultivated for 24, 96, or 144 hours. (Data of a representative experiment shown).
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days 1 and 4 were 17.6% and 14.6%, respectively (Fig.
3d). In addition, the ATP/DNA ratio from homogenized
slices did not change significantly during the time frame
between day 1 and day 4 of culture. A prolonged cultiva-
tion, however, turned out to be ineffectual: In the majority
of the cases investigated there was a gradual decline of via-
bility starting at day 5 (representative result in Fig. 3e).
Ex vivo treatment of tissue slices with taxol
To study the activity of an anticancer drug in this tissue
culture model we treated 10 tumor samples with different
concentrations of taxol for 72 hours. Figure 4a shows a
representative result of one sample evaluated both by
three-color viability assay and histological examination.
TMRM accumulation was significantly reduced (images
shown in Fig. 4a and quantification in Fig. 4b, left panel)
while nuclear staining of dead cells with Picogreen
increased following treatment of tissue slices with taxol in
a dose-dependent manner (Fig. 4a and Fig. 4b, right
panel). The low magnification corresponds to approxi-
mately 10% of the total slice area and is representative for
the complete tissue slice demonstrating that almost all
cells die in the presence of higher taxol concentrations in
this tumor sample (Fig. 4a). Histological examination
revealed an increasing number of disintegrated cells in the
presence of high taxol concentrations (Fig. 4a). The over-
all response to taxol in the 10 tumor samples investigated
is shown in figure 4c. The proportion of viable cells (ratio
TMRM+ and SYTO®63+ cells to total cells; Fig. 4c, left
panel) decreased whereas dead cells (ratio Picogreen+
cells to total cells; Fig. 4c, middle panel) increased signif-
icantly in a dose-dependent manner. This result was mir-
rored by quantification of the ATP/DNA ratio in slice
homogenates (Fig. 4c right panel). The response to taxol
determined for each individual tumor turned out to be
heterogeneous. One tumor sample was almost completely
resistant to taxol whereas 6 tumors turned out to be highly
sensitive to higher taxol concentrations: incubation of
slices from these tumors in the presence of 6.8µg/ml or
13.6µg/ml taxol for 4 days induced cell death in almost all
cells as determined by an almost complete staining with
Picogreen and by ATP breakdown. An intermediate
response to taxol was observed in 3 tumors.
The activity of taxol was also determined in sections from
paraffin embedded slices by immunohistochemical detec-
tion of active caspase 3 and BrdU incorporation. Treat-
ment of slices with taxol led to a decrease of BrdU positive
cells and an increase of active caspase 3 (Fig. 4d).
Identification of tumor compartments
As shown in figure 5a (left panel), epithelial cells can be
identified using a fluorescent-labeled antibody recogniz-
ing Ep-CAM (anti-HEA-125 antibody) in viable tissues.
The morphology of the epithelial compartment was iden-
tical to that observed in the same tumor examined imme-
diately after surgery by conventional
immunohistochemistry using HEA antibody (Fig. 5a,
middle panel) or cytokeratin 18 (CK18) antibody as epi-
thelial markers (Fig. 5a, right panel).
The vascular network was visualized by staining slices
with PE-labeled anti-CD34 antibody or FITC-conjugated
UEA-1. As shown in figure 5b the morphology of this net-
work was comparable to that observed in paraffin embed-
ded material stained with endothelial-specific antibodies,
such as CD34 [18].
To simultaneously identify epithelial cells and investigate
cell viability following taxol treatment the two-color fluo-
rescent viability assay consisting of SYTO®63 and PI was
combined with the detection of Ep-CAM. Almost all epi-
thelial cells (green) were viable in the control (negative for
PI) whereas epithelial cells (green) were positive for
nuclear PI staining (red) in taxol treated slices (Fig. 5c).
The tumor shown in this figure was highly sensitive to
taxol as many dead epithelial cells were detected even at
the lowest concentration used.
Discussion
Although most of the research into cancer drug sensitivity
ex vivo was initially based upon disaggregated tumors and
single cell culture experiments [19,20], it has now become
clear that the tumor environment has a wide influence on
the resistance of cancer cells to therapy [21]. Cell-cell and
cell-matrix interactions responsible for this impact have
been studied in 2D and 3D in vitro culture models [22-
24], in spheroid models [25,26] and in co-culture experi-
ments using immortalized tumor cell lines and primary
fibroblasts [27]. However, these interactions are likely to
be extremely complex and specific for each individual
tumor  in vivo [21]. It is therefore of great interest to
advance tissue culture models for studying the activity of
anticancer drugs and small molecule inhibitors in an
intact tumor environment of individual tumors – particu-
larly as there are different targets within the tumor tissue:
the epithelial tumor cells themselves and the surrounding
non-tumorgenic cell types. We have combined a tissue
culture method described by Krumdieck et al. [14] and
Hood & Parham [15] with a novel read out system for a
rapid assessment of drug efficacy together with the simul-
taneous identification of different cell types within the
fresh tissue material. With this culture technique it was
possible to cultivate freshly excised tumor material from
22 of 25 patients in the presence or absence of drugs ex
vivo for at least 4 days without significant loss of cell via-
bility. Therefore, this technique may provide a valid tool
to investigate drug resistance and effectiveness of antican-
cer drugs in a large number of tumor samples. The accu-
rately defined thickness of the tissue slices (200µm)BMC Cancer 2006, 6:86 http://www.biomedcentral.com/1471-2407/6/86
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Influence of Taxol treatment on cell viability Figure 4
Influence of Taxol treatment on cell viability: (a)Three-color fluorescence viability assay (top and middle) and hematox-
ylin/eosin staining (bottom) of slices treated with different taxol concentrations for 72 hours (images of a representative exper-
iment). (b) The numbers of TMRM+, SYTO®63+, and Picogreen+ cells in tumor slices from (a) were evaluated by counting of at 
least 50 cells from three different areas of different images. Viable cells were assessed as numbers of TMRM+ and SYTO®63+ 
cells in relation to total cells (left panel). Dead cells were evaluated as numbers of Picogreen+ cells in relation to total cells 
(right panel). Values reflect means ± SEM. (c) Dose dependent effect of taxol treatment on cell viability determined by quantifi-
cation of TMRM+, SYTO®63+, and Picogreen+ cells in non fixed tumor slices (left and middle panel) and by evaluation of ATP/
DNA ratio in slice homogenates (right panel). Ratios of controls were set to 100%, and the relative ratios of the taxol treated 
tissues were calculated. Data represent range, median and 25 to 75% percentile of a set of 10 experiments. Kruskal-Wallis test: 
p < 0.0001 for all three. (d) Effect of taxol treatment on proliferation and apoptosis. Formalin-fixed and paraffin-embedded 
slices were stained with anti-BrdU or anti-caspase 3 antibodies by conventional immunohistochemistry and counterstained 
with hematoxylin.
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Identification of different cell types within tumor slices Figure 5
Identification of different cell types within tumor slices: (a) epithelial cells were identified using an anti-HEA-125 anti-
body recognizing an epithelial specific adhesion molecule (Ep-CAM). The morphology of epithelial cell clusters in slices culti-
vated for 96 hours (left panel) was compared to that observed in sections from paraffin embedded material from the same 
tumor prepared immediately after surgery labeled either with anti-HEA-125 (middle panel; counterstained with hematoxylin) 
or anti-cytokeratin 18 (right panel; counterstained with hematoxylin). (b) To visualize the vascular network tissue slices cul-
tured for 96 hours were directly labeled using a PE-conjugated CD34 antibody (left panel) or a FITC-conjugated Ulex europaeus 
Agglutinin I (UEA-1; middle panel). The morphology of this network is comparable to that observed in paraffin embedded 
material obtained directly after surgery and stained with CD34 antibody (right panel, counterstained with hematoxylin). (c) 
Simultaneous staining of epithelial cells and determination of cell viability in slices treated with or without taxol for 72 hours. 
Epithelial cells were identified using a FITC-conjugated anti-HEA-125 antibody (green). Cell viability was determined using the 
two DNA selective dyes PI (red) and SYTO®63 (blue).
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allows a smooth diffusion of nutrients, drugs, and anti-
bodies. Fluorescent labeled taxol and antibodies were
found to be distributed throughout the slice (Additional
File 1). Following treatment, the tissues can be analyzed
on different levels (Fig. 1). Non fixed slices stained with
TMRM, SYTO®63, Picogreen/PI, and/or fluorescent-conju-
gated antibodies for estimation of drug sensitivity and
identification of cell type can be further utilized for con-
ventional immunohistochemistry. After formalin-fixation
it is possible to take multiple 3µm sections from the par-
affin embedded slices at later date. It is also feasible to pre-
pare cryo-sections from frozen tissue slices for laser
capture microdissection allowing the separation of the
different cellular tumor compartments to analyze them
separately via genomic or proteomic approaches. Further-
more, homogenized slices can be used for ATP and DNA
quantification to assess the overall viability of the tumor
tissue. In addition, the culture supernatant can be ana-
lyzed for metabolites and peptides or proteins released as
a consequence of cell death such as CK18 [28].
Furthermore, this in vitro culture system provides a tool
for studying the differential responses of specific tumor
compartments to anticancer drugs and may therefore e.g.
allow evaluating whether manipulation of the stromal
compartment alters drug response of tumor cells. This is
of utmost importance for the development of novel com-
binatorial strategies involving novel pharmacological
compounds such as signal transduction inhibitors and
interfering RNAs (siRNAs), particularly as these sub-
stances specifically target either the tumor or the stromal
compartment. Together with well established models
such as 3D culture systems and animal tumor xenografts,
this tissue slice model will be helpful to enhance the
understanding of anti-tumor drug activity.
Conclusion
This method has potential significance for studying tumor
responses in the complex environment of a primary can-
cer tissue enabling a molecular profiling of all tumor com-
partments using laser microdissection techniques.
Subsequently, it can be used to analyze the molecular
response of each tissue component to both cytotoxic
drugs and signal transduction inhibitors via genomic or
proteomic approaches. Therefore, this method opens the
window for extensive molecular studies on the biological
effects of conventional and innovative treatment strate-
gies.
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